Last reviewed · How we verify

NCT06909838

Radial Shockwave for Spasticity in Children With CP or ABI

Completed NA Last updated 11 July 2025
What this trial tests

NA trial testing radial Extracorporeal shockwave therapy (rESWT) in Spasticity Due to Cerebral Palsy in 24 participants. Completed in 5 June 2025.

Timeline
24 September 2024
Primary endpoint
5 June 2025
5 June 2025

Quick facts

Lead sponsorGymna Uniphy
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designcrossover
Maskingdouble
Primary purposetreatment
Enrollment24
Start date24 September 2024
Primary completion5 June 2025
Estimated completion5 June 2025
Sites1 location across Belgium

Drugs / interventions tested

Conditions studied

Sponsor

Gymna Uniphy

Who can join

Adults 6 to 18, any sex, with Spasticity Due to Cerebral Palsy or Spasticity Post-Traumatic Brain Injury. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The goal of this clinical trial is to determine if radial Extracorporeal shockwave therapy (rESWT) reduces spasticity in children with Cerbral Palsy (CP) or traumatic brain injury (TBI). The main questions it aims to answer are: * Is it feasible to implement radial shockwave therapy in conventional physiotherapy plan in children with CP or TBI? * Is it safe and effective to use rESWT for reducing spasticity in children with CP or TBI? Participants will receive a 4 week therapy intervention, as add on to the conventional physio (usual care), including one rESWT session per week for a total of 4 sessions.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Spasticity Due to Cerebral Palsy

Currently open trials in the same condition.

Other Gymna Uniphy trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06909838.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing